Sexual dysfunction
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2026.
Clinical MilestonesViewHide
- 2026-07-23Postpartum Vaginal Estrogen for Sexual Function in Breastfeeding Patients: A Randomized Controlled TrialResults expected Q4 2026
- 2026-07-23ClinicalPostpartum Vaginal Estrogen for Sexual Function in Breastfeeding Patients: A Randomized Controlled TrialResults expected Q4 2026
Therapeutic landscape
Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.
Approval — Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective,… (2017)
Approval — Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexu… (2013)
Approval — Treatment of men with erectile dysfunction, which is the inability to achieve or maintain… (2009)
Approval — Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to… (2003)
Clinical trials
The current development programme across all trial phases.
Regulatory timeline
Drug regulatory events matched to this condition by indication — EMA.
European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.